Outcomes of Treat-and-Extend versus Pro Re Nata Anti-VEGF Injections for Myopic Macular Neovascularization in Patients in the United States

被引：0
|
作者：
Swaminathan, Shreya [1 ]
Mahmoudzadeh, Raziyeh [2 ]
Wakabayashi, Taku [2 ]
Bowers, Mallory Elva [1 ]
Abishek, Robert [2 ]
Salabati, Mirataollah [2 ]
Hsu, Jason [2 ]
Dunn, James P. [2 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] OUTCOMES OF PRO RE NATA VERSUS TREAT-AND-EXTEND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR MYOPIC MACULAR NEOVASCULARIZATION IN MULTIETHNIC PATIENTS IN THE UNITED STATES
    Swaminathan, Shreya
    Mahmoudzadeh, Raziyeh
    Wakabayashi, Taku
    Bowers, Mallory
    Momenaei, Bita
    Abishek, Robert M.
    Salabati, Mirataollah
    Hsu, Jason
    Dunn, James P.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (12): : 2057 - 2065
  • [2] Strategies of Intravitreal Injections with Anti-VEGF: "Pro re Nata versus Treat and Extend"
    Hufendiek, K.
    Pielen, A.
    Framme, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (08) : 930 - 939
  • [3] Pro Re Nata versus treat-and-extend anti-VEGF dosing strategies for the treatment of macular oedema in retinal vein occlusion: 12-month outcomes
    Kostin, Vasil
    Horak, Martin
    Zamirska, Wiktoria
    Bakr, Yasmin
    Fischer, M. Dominik
    Issa, Peter Charbel
    Kiire, Christine
    Stone, Niamh
    De Silva, Samantha R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes
    Toto, Lisa
    Viggiano, Pasquale
    Quarta, Alberto
    Grassi, Mariaoliva
    De Nicola, Chiara
    Aloia, Raffaella
    D'Aloisio, Rossella
    Boscia, Giacomo
    Boscia, Francesco
    Porreca, Annamaria
    Di Nicola, Marta
    Savastano, Maria Cristina
    Mastropasqua, Rodolfo
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 282 - 291
  • [5] Results of Switching from Pro Re Nata to Treat-and-Extend Regimen in Treatment of Patients with Type 3 Neovascularization
    Kim, Jae Hui
    SEMINARS IN OPHTHALMOLOGY, 2020, 35 (01) : 33 - 40
  • [6] Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial
    Maguire, Matthew J.
    Laidlaw, Alistair
    Hammond, Christopher
    Muqit, Mahiul Muhammed Khan
    Steel, David
    Dinah, Christiana
    Lee, Edward
    Hillier, Roxane
    Almeida, Goncalo
    Hussain, Rumana
    Gordon-Bennet, Patel
    Hughes, Edward
    Alexander, Philip
    Vaideanu-Collins, Daniela
    Jackson, Tim
    JAMA OPHTHALMOLOGY, 2024, 142 (09) : 837 - 844
  • [7] RANIBIZUMAB 0.5 MG TREAT-AND-EXTEND VERSUS PRO-RE-NATA IN VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA: RETAIN STUDY
    Ricci, F.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 459 - 459
  • [8] Two-year outcomes of patients receiving anti-VEGF treatment for neovascular age-related macular degeneration on a treat-and-extend regimen
    Eng, Victor
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [9] Ganglion cell complex changes in wet AMD patients treated with anti-VEGF intravitreal injections according to a treat-and-extend protocol
    Cao, Jessica
    Mongy, Mohamed
    Ferreira, Lisia
    Brent, Michael Henry
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (02): : 96 - 101
  • [10] Switching from pro re nata to treat-and-extend regimen improves visual acuity in patients with neovascular age-related macular degeneration
    Kvannli, Line
    Krohn, Jorgen
    ACTA OPHTHALMOLOGICA, 2017, 95 (07) : 678 - 682
12345